Keywords: فاکتور IX; aFVII; activated FVII; AHA; acquired hemophilia A; anti-hFVIII; anti-human FVIII; aPCC; activated prothrombin complex concentrate; aPTT; activated partial thromboplastin time; AT; antithrombin; AUC; area under the curve; BPA; bypassing agent; BU; Bethesda
مقالات ISI فاکتور IX (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فاکتور IX; Bleeding; Hemarthrosis; Factor concentrate; Factor VIII; Factor IX; Inhibitors; Gene therapy; Bispecific antibody;
Keywords: فاکتور IX; Medical diagnosis; Factor IX; Thrombin; Bleeding; Blood clotting;
Keywords: فاکتور IX; Haemophilia A; Haemophilia B; Prophylaxis; Factor VIII; Factor IX;
Keywords: فاکتور IX; Early intervention (education); Hemophilia; Illness behavior; Pain; Quality of life; Rehabilitation; FVIII; factor VIII; FIX; factor IX; IBQ; Illness Behavior Questionnaire; RMAV; repeated-measures analysis of variance; VAS; visual analog scale;
Keywords: فاکتور IX; aPCC; activated prothrombin complex concentrate; aPL; antiphospholipid; FIX; factor IX; FMD; flow-mediated dilatation; FV; factor V; FVIII; factor VIII; HA; hemophilia A; HB; hemophilia B; HIV; human immunodeficiency virus; IMT; intima-media thickness; MT
Keywords: فاکتور IX; antenatal diagnosis; carrier; factor IX; factor VIII; haemophilia; inhibitors; recombinant
Keywords: فاکتور IX; Haemophilia; Factor VIII; Factor IX; Gene therapy; Vectors
Keywords: فاکتور IX; Lectin; von Willebrand factor; Factor IX; Hamster cell lines; Sambucus nigra agglutinin (SNA)
Keywords: فاکتور IX; BL/6; C57BL/6; EC; Endothelial cell; ePCR; Endothelial protein C receptor; FIX; Factor IX; FX; Factor X; HEQ; Hirudin Equivalent”; LPS; Lipopolysaccharide; PSGL-1; P-selectin glycoprotein ligand-1; TF; Tissue factor; TAT; Thrombin anti-thrombin; WT; Wil
Keywords: فاکتور IX; Hemostasis; Factor IX; Thrombin; Anticoagulant; Heparin; Factor IX-binding protein; Aptamer;
An update on factor XI structure and function
Keywords: فاکتور IX; Factor XI; Factor XIa; Prekallikrein; Factor XIIa; Factor IX;
Full Length ArticleChoice of factor VIII/IX regimen in adolescents and young adults with severe or moderately severe haemophilia. A French national observational study (ORTHem 15-25)
Keywords: فاکتور IX; Factor VIII; Factor IX; Prophylaxis; On-demand treatment; Age groups; Haemorrhage;
Full Length ArticleGeneration and characterization of aptamers targeting factor XIa
Keywords: فاکتور IX; RNA aptamers; Factor XIa; Factor IX; Anticoagulant agents; Blood coagulation;
MiR-128 and miR-125 regulate expression of coagulation Factor IX gene with nonsense mutation by repressing nonsense-mediated mRNA decay
Keywords: فاکتور IX; MicroRNA; Hemophilia; Factor IX; Nonsense mutation; NMD
Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigmâ¢4)
Keywords: فاکتور IX; ABR; annualised bleeding rate; AEs; adverse events; CHO; Chinese hamster ovary; CI; confidence interval; EDs; exposure days; ELISA; enzyme-linked immunosorbent assay; FIX; factor IX; IQR; interquartile range; PEG; polyethylene glycol; PTPs; previously tre
Pharmacokinetics, Efficacy, and Safety of Nonacog Alfa in Previously Treated Patients with Moderately Severe to Severe Hemophilia B
Keywords: فاکتور IX; BeneFIX; factor IX; hemophilia B; nonacog alfa; pharmacokinetics;
Część I: Wytyczne postępowania w hemofilii A i B niepowikłanej inhibitorem czynnika VIII i IX (wydanie zaktualizowane)
Keywords: فاکتور IX; hemofilia A; hemofilia B; profilaktyka; krwawienia; wytyczne; Polska; czynnik VIII; czynnik IXHaemophilia A; Haemophilia B; Prophylaxis; Bleeding; Guidelines; Poland; Factor VIII; Factor IX
Quantifying vitamin K-dependent holoprotein compaction caused by differential γ-carboxylation using high-pressure size exclusion chromatography
Keywords: فاکتور IX; High-pressure size exclusion chromatography; Vitamin K-dependent protein; γ-Carboxylation; Factor IX;
Virus removal capacity at varying ionic strength during nanofiltration of AlphaNine® SD
Keywords: فاکتور IX; Viral safety; Nanofiltration; Factor IX; AlphaNine® SD; Ion strength; Virus removal;
The mechanism underlying activation of factor IX by factor XIa
Keywords: فاکتور IX; Factor XIa; Factor IX; Exosite
Biodistribution of the recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in rats
Keywords: فاکتور IX; FIX; factor IX; FIXa; activated FIX; rFIX; recombinant FIX; pdFIX; plasma-derived FIX; rIX-FP; recombinant fusion protein linking factor IX with albumin; QWBA; quantitative whole-body autoradiography; LSC; liquid scintillation counting; LMW; low-molecular
Target-mediated clearance and bio-distribution of a monoclonal antibody against the Kunitz-type protease inhibitor 2 domain of Tissue Factor Pathway Inhibitor
Keywords: فاکتور IX; AUC; area under the curve; Cl; clearance; DAB; 3,3â²-diaminobenzidine; dIF; double immunofluorescence; EGFR; epidermal growth factor receptor; GAG; glycosaminoglycans; GPI; glycosylphosphatidylinositol; FVIII; Factor VIII; FIX; Factor IX; FXa; Factor Xa;
Hepatocyte clearance and pharmacokinetics of recombinant factor IX glycosylation variants
Keywords: فاکتور IX; Hepatocyte; Clearance; Coagulation; Factor IX; Asialoglycoprotein receptor (ASGPR);
Overexpression of factor VII ameliorates bleeding diathesis of factor VIII-deficient mice with inhibitors
Keywords: فاکتور IX; FVII; Factor VII; FVIII; Factor VIII; AAV; adeno-associated virus; F8KO; Factor VIII knock out; HCR; hepatic control region; HAAT; human alpha-1 antitrypsin; CMV; cytomegalovirus; SV40; simian virus 40; PCR; polymerase chain reaction; PT; prothrombin time
Phase I/II, open-label, multicenter, safety, efficacy and PK study of a recombinant coagulation factor IX albumin fusion protein (rIX-FP) in subjects with hemophilia B
Keywords: فاکتور IX; Hemophilia B; Factor IX; Albumin fusion protein; Pharmacokinetics; Recombinant albumin; PROLONG-9FPAE, adverse event; AUC, area under the curve; EOS, end of study; FIX, factor IX; IR, incremental recovery; pdFIX, plasma-derived FIX; PK, pharmacokinetic; r
PROLONG-9FP clinical development program – phase I results of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP)
Keywords: فاکتور IX; Hemophilia B; Factor IX; Albumin fusion protein; Recombinant albumin; PROLONG-9FPAE, adverse event; AUC, area under the curve; cDNA, complementary DNA; FIX, factor IX; IR, incremental recovery; pdFIX, plasma-derived FIX; PK, pharmacokinetic; rFIX, recombi
Innovative coagulation factors: albumin fusion technology and recombinant single-chain factor VIII
Keywords: فاکتور IX; Hemophilia B; Albumin fusion; Activated factor VII; Factor VIII; Factor IX; Half-lifeaPTT, activated partial thromboplastin time; FcRn, neonatal Fc receptor; FIX, factor IX; FVIIa, activated factor VII; FVIII, factor VIII; IgG, immunoglobulin G; PK, pharm
Protein sieving characteristics of sub-20-nm pore size filters at varying ionic strength during nanofiltration of Coagulation Factor IX
Keywords: فاکتور IX; Nanofiltration; C4BP; Factor IX;
Plasma derivatives: New products and new approaches
Keywords: فاکتور IX; Hemophilia; Factor VIII; Factor IX; Immunogenicity; Protein therapeutics; Pharmacogenetics
Protein Z/protein Z-dependent protease inhibitor system in human non-small-cell lung cancer tissue
Keywords: فاکتور IX; ABC; avidin - biotin complex technique; antibody T2G1; antibody directed to fibrin II (des fibrinopeptide B fibrin); antibody 1-8C6; antibody which reacts with fibrinogen or des fibrinopeptide A fibrin but not with des fibrinopeptide B fibrin; AT; antit
Anticoagulation factor I, a snaclec (snake C-type lectin) from Agkistrodon acutus venom binds to FIX as well as FX: Ca2+ induced binding data
Keywords: فاکتور IX; Agkistrodon acutuss; ACF I; Snaclec; Ca2+; Factor IX;
Challenges in the laboratory analyses of bleeding disorders
Keywords: فاکتور IX; aPTT; activated partial thromboplastin time; CAT; calibrated automated thrombography; ETP; endogenous thrombin potential; EQA; external quality assurance; FVIII; factor VIII; FIX; factor IX; FVIII:C; coagulation activity of FVIII; FIX:C; coagulation activ
Global haemostasis assays, from bench to bedside
Keywords: فاکتور IX; α; angle that assesses rate of clot formation; α2M; α2-macroglobulin; AMC; 7-amino-4-methylcoumarine; AT; antithrombin; AUC; area under the curve; APC; activated protein C; aPTT; activated partial thromboplastin time; A10; the amplitude after ten minut
Les anticorps anti-FVIII et anti-FIX
Keywords: فاکتور IX; Hémophilie A; hémophilie B; inhibiteurs; coagulation; réponse immunitaire; facteur VIII; facteur IX; Haemophilia A; haemophilia B; inhibitors; coagulation; immune response; factor III; factor IX;
Laboratory identification of factor inhibitors: an update
Keywords: فاکتور IX; APTT; Bethesda assay; Factor inhibitors; lupus inhibitor; mixing tests; replacement therapy; APTT; activated partial thromboplastin time; aVWS; acquired von Willebrand syndrome; DIC; disseminated intravascular coagulation; dRVVT; dilute Russell's viper
Management of haemophilia
Keywords: فاکتور IX; antenatal diagnosis; carrier; factor VIII; factor IX; haemophilia; inhibitors; recombinant
Recent advances in the development of coagulation factors and procoagulants for the treatment of hemophilia
Keywords: فاکتور IX; Hemophilia; Factor IX; Factor VIII; Coagulation
Calcium Binding to a Factor IX Fc Fusion Protein and Effects on HigherâOrder Structure
Keywords: فاکتور IX; biotechnology; biopharmaceuticals characterization; protein structure; calorimetry (ITC); spectroscopy; analytical ultraâcentrifugation; factor IX; fusion protein; calcium binding;
Wound healing in hemophilia B mice and low tissue factor mice
Keywords: فاکتور IX; Wound healing; Hemophilia; Factor IX; Factor VIIa; Tissue factor
Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven®) therapy in haemophilia a patients
Keywords: فاکتور IX; TEG; Thromboelastography; rFVIIa; recombinant Factor VIIa; FVIII; Factor VIII; FIX; Factor IX; FX; Factor X; tPA; tissue plaminogen activator; TF; tissue factor; R-time; Reaction time; MTG; maximum thrombus generation; MA; maximum amplitude; pd-aPCC; acti
Virus removal from factor IX by filtration: Validation of the integrity test and effect of manufacturing process conditions
Keywords: فاکتور IX; Virus removal; Factor IX; Plasma products; Planova® 15N filters; Process limits; Integrity test
Effect of Ca2+ and Mg2+ concentration in culture medium on the activation of recombinant factor IX produced in Chinese hamster ovary cells
Keywords: فاکتور IX; Activation of factor IX; Calcium ions; CHO cells; Factor IX; Magnesium ions
Prophylactic therapy in haemophilia
Keywords: فاکتور IX; Haemophilia A; Haemophilia B; Factor VIII; Factor IX
Affinity adsorption of human vitamin K-dependent coagulation factor IX onto heparin-like poly (styrene sodium sulfonate) adsorbent
Keywords: فاکتور IX; Factor IX; Vitamin K-dependent coagulation factors; Poly (styrene sodium sulfonate); Protein adsorption; Adsorption isotherm; Heparin-like sorbent
Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, α2-macroglobulin, factor IXa and factor VIII
Keywords: فاکتور IX; LRP; Complement-type repeats; Factor VIII; Factor IX; RAP; Alpha-2-macroglubulin
Immune response after neonatal transfer of a human factor IX-expressing retroviral vector in dogs, cats, and mice
Keywords: فاکتور IX; FIX; Factor IX; IV; intravenous; hFIX; human FIX; RV; retroviral vector; MPS I; mucopolysaccharidosis I; CTL; cytotoxic T lymphocyte; cIDUA; canine α-l-iduronidase; WPRE; woodchuck hepatitis virus post-transcriptional regulatory element; IU; internationa
Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5
Keywords: فاکتور IX; Adeno-associated virus; Rodent; Capsid; Transduction; Neutralization; Factor IX; Liver; Retina; Genome walking
Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study
Keywords: فاکتور IX; TF; tissue factor; FVII; factor VII; FVIIa; factor VIIa; FFR-FVIIa; FVIIa blocked in the active site with phenylalanyl-phenylalanyl-arginyl-chloromethyl ketone; FX; factor X; FIX; factor IX; PCR; polymerase chain reaction; EDTA; ethylenediaminetetraacetic
Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature
Keywords: فاکتور IX; APC; activated protein C; aPTT; activated partial thromboplastin time; AT; antithrombin; BMI; body mass index; CEE; conjugated equine estrogen; DVT; deep vein thrombosis; HERS; Heart and Estrogen/Progestin Replacement Study; E2; estradiol; ET; estrogen th